Title: Autoimmune Disease Diagnostics Market to grow with 2.5% CAGR from 2017 to 2024
1Autoimmune Disease Diagnostics Market to grow
with 2.5 CAGR from 2017 to 2024 Global Market
Insights Inc.
Fuel Cell Market size worth 25.5bn by 2024
2Key Insights from Autoimmune Disease Diagnostics
Market
- Global Market Insights, Inc., Autoimmune Disease
Diagnostics Market size is set to exceed USD 16
billion by 2024. - Rising prevalence of autoimmune disorders such as
rheumatoid arthritis, Hashimotos thyroiditis,
type 1 diabetes and Graves disease will drive
the global autoimmune disease diagnostics market.
- Growing patient awareness levels pertaining to
autoimmune diseases due to the launch of national
awareness campaigns will further fuel industry
expansion. - Presence of favorable government initiatives such
as The Cooperative Study Group for Autoimmune
Disease Prevention (CSGADP) and NIHs HLA Region
Genetics in Immune-Mediated Diseases Consortium
for autoimmune diseases diagnosis and treatment
will augment industry growth. - Advancement in technology such as lab automation
developed to cater the need of increasing
diagnostic procedures is another growth rendering
driver.
3Continued...
- Lack of skilled healthcare professionals and
experts coupled with long and complex diagnosis
process for autoimmune disease will hamper
business growth. - Localized autoimmune disease diagnostics held
higher market share in 2016 and should show a
similar trend over the forecast years owing to
the increasing prevalence of gastrointestinal
autoimmune diseases. - UK autoimmune disease diagnostics market should
witness considerable growth over the coming
years. - China autoimmune disease diagnostic market should
grow at robust rate with growing prevalence of
autoimmune pancreatitis, improving healthcare
infrastructure coupled with increased RD efforts
and rising patient awareness levels. - Some of the key industry players operating in
global autoimmune disease diagnostics market are
Siemens Healthcare, Roche Diagnostics, Abbott
Laboratories, BioMerieux, EUROIMMUN and Quest
Diagnostics.
4Germany Autoimmune Disease Market, By Product,
2013 - 2024 (USD Million)
5 Browse Full Market Research Report On
Autoimmune Disease Diagnostics Market _at_
http//bit.ly/2gc7zGd Request for a Sample
of this Research Report _at_ https//www.gminsights.c
om/request-sample/detail/618
6360 Analysis
- Product Analysis
- Localized segment accounted for largest market
share in 2016 and will grow at an approximately
2.1 CAGR over the forecast timeframe. Systemic
segment will witness robust growth with CAGR of
over 3.9. The systemic diseases are difficult to
diagnose. However, due to the continuous research
activities and increasing awareness levels, the
diagnosis rates are expected to increase in the
future. - Regional Analysis
- U.S. accounted for largest market share in 2016
owing to the high and steadily increasing
prevalence of rheumatoid arthritis and systemic
lupus erythematosus. Autoimmune diseases cause
significant economic burden in U.S. and are one
of the top leading cause of death in female
children and women of all age. - Competitive Market Share
- Some of the players in global autoimmune disease
diagnostics market are Abbott Laboratories,
Siemens Healthcare, Beckman Coulter Inc. and
Quest Diagnostics. Innovative product launch and
expansion through strategic partnership are
foremost strategies adopted by the players to
garner higher market share.
7 Stay In Touch Website www.gminsights.com Soci
al Media